To study the development of cardiopulmonary bypass (CPB) in the past 8 years and to come up with predictions and recommendations for the future in China.
Somanetics Corporation (Nasdaq: SMTS, news) today announced that the results of the first randomized, prospective and blinded study using the Company’s INVOS® […]
